Trial Outcomes & Findings for Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder (NCT NCT00391430)

NCT ID: NCT00391430

Last Updated: 2021-07-21

Results Overview

Salivary cortisol levels (measured before, during, and after the fMRI)

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

39 participants

Primary outcome timeframe

Measured 3 days before and after treatment and 1 day during fMRI

Results posted on

2021-07-21

Participant Flow

Participant milestones

Participant milestones
Measure
Sertraline
Participants will receive treatment with sertraline Sertraline: Dosage: up to 100 mg/day; Frequency: once per day; Duration: 12 weeks
Control
Participants assigned to the control condition will receive no treatment
Cognitive Behavioral Therapy
Participants will receive cognitive behavioral therapy Cognitive behavioral therapy (CBT): CBT consists of sixteen 1-hour sessions during a period of 12 weeks.
Overall Study
STARTED
8
0
31
Overall Study
COMPLETED
5
0
19
Overall Study
NOT COMPLETED
3
0
12

Reasons for withdrawal

Reasons for withdrawal
Measure
Sertraline
Participants will receive treatment with sertraline Sertraline: Dosage: up to 100 mg/day; Frequency: once per day; Duration: 12 weeks
Control
Participants assigned to the control condition will receive no treatment
Cognitive Behavioral Therapy
Participants will receive cognitive behavioral therapy Cognitive behavioral therapy (CBT): CBT consists of sixteen 1-hour sessions during a period of 12 weeks.
Overall Study
Withdrawal by Subject
3
0
12

Baseline Characteristics

Study was terminated due to poor enrollment. Data collected insufficient to conduct meaningful analyses.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
Participants assigned to the control condition will receive no treatment
Sertraline
n=8 Participants
Participants will receive treatment with sertraline Sertraline: Dosage: up to 100 mg/day; Frequency: once per day; Duration: 12 weeks
Cognitive Behavioral Therapy
n=31 Participants
Participants will receive cognitive behavioral therapy Cognitive behavioral therapy (CBT): CBT consists of sixteen 1-hour sessions during a period of 12 weeks.
Total
n=39 Participants
Total of all reporting groups
Sex: Female, Male
Female
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
Sex: Female, Male
Male
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.
0 Participants
Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

PRIMARY outcome

Timeframe: Measured 3 days before and after treatment and 1 day during fMRI

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Salivary cortisol levels (measured before, during, and after the fMRI)

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Measured on 1 day during two MRIs

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Fear response (measured during the fMRI) in response to positive fearful and neutral stimuli

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 30 minutes before and after treatment

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Assesses the full range of traumatic stressor over lifetime

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 30 minutes before and after treatment

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Assesses severity and frequency of PTSD symptoms and provides information for diagnosis

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 1 hour before and after treatment

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Provides assessment of all anxiety and mood disorder diagnoses

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 15 minutes before and after treatment

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

measure of frequency and severity of panic attacks

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured weekly throughout the study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Assesses functional status of individual

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured weekly throughout the study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

Assesses improvement in functioning

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured at baseline

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

social and demographic characteristics of the individual

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 10 minutes, before, during, and after treatment

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses worry and rumination

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 10 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

self-report measure of PTSD symptoms

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 10 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses a wide range of symptoms regarding the distress they cause

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 3 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses ability to regulate mood states

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 10 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assess experience of anger as both a state and trait like phenomenon

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 2 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses difficulty in identifying and naming feelings

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 10 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses types and severity of anxiety

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 3 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses type and severity of depression

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 2 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses type and severity of interpersonal problems

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 2 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assesses social adjustment

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured 2 times throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

review safety information related to fMRI procedure

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assessment of medical problems in past 12 months

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Measured throughout study

Population: Multiple efforts were made to locate the study data, but were unsuccessful (study was terminated, data was not saved). No study data are available.

assessment of type and frequency of use of medical services

Outcome measures

Outcome data not reported

Adverse Events

Sertraline

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Cognitive Behavioral Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Marylene Cloitre

NYU Langone

Phone: 2122632471

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place